Reed Smith Partner Nikki Bhargava spoke with AdExchanger about knowns – and unknowns – on the privacy as we gear up for the ...

AdExchanger is where marketers, agencies, publishers and tech companies go for the latest information on the trends that are ...

Google and the DOJ had 90 minutes apiece for closing arguments and Judge Brinkema could ask questions throughout. She had ...

While tech companies jump on the curation bandwagon, publishers navigate a new normal in programmatic advertising, where they often don’t have a say.

Rumors are swirling that DV is exploring an acquisition of Lumen Research to add eye-tracking capabilities to its attention ...

Is owning content a “conflict of interest” among current OS providers, and, if so, how does that affect the CTV landscape?

Enjoy this weekly comic strip from AdExchanger.com that highlights the digital advertising ecosystem ...

% ...

The sky is blue, but money is green. Put another way, despite Bluesky’s growing popularity, brands aren’t quite ready to jump ...

The odds of RFK Jr. implementing a ban on TV drug ads are slim, says our guest this week, BranchLab’s Josh Walsh. Still, pharma advertisers could face other regulatory changes over the next four years ...

The odds of RFK Jr. implementing a ban on TV drug ads are slim, says our guest this week, BranchLab’s Josh Walsh. Still, pharma advertisers could face other regulatory changes over the next four years ...